Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Clear all

184 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20025
20038
20045
200514
200610
20075
20087
20095
201010
20117
20126
20137
20147
20155
20164
20173
20183
20194
20204
20219
20221
20233
20242
20254
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132
Unknown status18
Terminated15
Recruiting11
Withdrawn4
Active, not recruiting2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)20
Assistance Publique - Hôpitaux de Paris6
Boehringer Ingelheim6
Novartis Pharmaceuticals5
Merck Sharp & Dohme LLC4
Sanofi4
AstraZeneca3
Brigham and Women's Hospital3
GlaxoSmithKline3
Population Health Research Institute3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction184
Cardiovascular Diseases54
Heart Diseases38
Myocardial Ischemia35
Acute Coronary Syndrome29
Stroke29
Coronary Disease28
Angina, Unstable21
ST Elevation Myocardial Infarction20
Heart Failure19

Trials

Showing 26 to 50 of 184. Each trial links to its page on Pharma Observatory.

84 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.